Literature DB >> 6643610

Gas chromatographic--mass spectrometric analysis of polyols in urine and serum of uremic patients. Identification of new deoxyalditols and inositol isomers.

T Niwa, N Yamamoto, K Maeda, K Yamada, T Ohki, M Mori.   

Abstract

A gas chromatographic--mass spectrometric method was applied to a study of polyols in urine and serum of normal subjects and uremic patients. 4-Deoxythreitol, 4-deoxyerythritol, 5-deoxyxylitol, 5-deoxyarabitol, 2-deoxyribitol, 6-deoxymannitol, 6-deoxygalactitol, neoinositol and chiroinositol were identified in normal urine as well as in uremic urine for the first time. In uremia the urinary excretion of myoinositol and chiroinositol was significantly increased. The serum levels of myoinositol, chiroinositol and scylloinositol were increased in the uremic patients, whereas the serum level of 1-deoxyglucose (1,5-anhydroglucitol) was significantly decreased in the uremic patients as compared with the normal subjects. These findings suggest the altered metabolism of chiroinositol and 1-deoxyglucose in the uremic state.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643610

Source DB:  PubMed          Journal:  J Chromatogr


  10 in total

1.  Reduction of plasma 1,5-anhydroglucitol (1-deoxyglucose) concentration in diabetic patients.

Authors:  T Yamanouchi; H Akanuma; T Nakamura; I Akaoka; Y Akanuma
Journal:  Diabetologia       Date:  1988-01       Impact factor: 10.122

2.  Enantioselective measurement of fungal D-arabinitol in the sera of normal adults and patients with candidiasis.

Authors:  B Wong; K L Brauer
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

3.  Levels of the Candida metabolite D-arabinitol in sera of steroid-treated and untreated patients with sarcoidosis.

Authors:  B Wong; R P Baughman; K L Brauer
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

4.  Genetic modification of Bacillus subtilis for production of D-chiro-inositol, an investigational drug candidate for treatment of type 2 diabetes and polycystic ovary syndrome.

Authors:  Ken-ichi Yoshida; Masanori Yamaguchi; Tetsuro Morinaga; Maya Ikeuchi; Masaki Kinehara; Hitoshi Ashida
Journal:  Appl Environ Microbiol       Date:  2006-02       Impact factor: 4.792

5.  An Enlarged Profile of Uremic Solutes.

Authors:  Hisae Tanaka; Tammy L Sirich; Natalie S Plummer; Daniel S Weaver; Timothy W Meyer
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

6.  The complex human urinary sugar profile: determinants revealed in the cross-sectional KarMeN study.

Authors:  Carina I Mack; Christoph H Weinert; Björn Egert; Paola G Ferrario; Achim Bub; Ingrid Hoffmann; Bernhard Watzl; Hannelore Daniel; Sabine E Kulling
Journal:  Am J Clin Nutr       Date:  2018-09-01       Impact factor: 7.045

7.  An Update on Measures of Preoperative Glycemic Control.

Authors:  Ledibabari M Ngaage; Emmanuel N Osadebey; Sebastian T E Tullie; Adekunle Elegbede; Erin M Rada; Elias K Spanakis; Nelson Goldberg; Sheri Slezak; Yvonne M Rasko
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-05-16

8.  Serum Myo-Inositol, Dimethyl Sulfone, and Valine in Combination with Creatinine Allow Accurate Assessment of Renal Insufficiency-A Proof of Concept.

Authors:  Jochen Ehrich; Laurence Dubourg; Sverker Hansson; Lars Pape; Tobias Steinle; Jana Fruth; Sebastian Höckner; Eric Schiffer
Journal:  Diagnostics (Basel)       Date:  2021-02-03

9.  Simple and non-invasive screening method for diabetes based on myoinositol levels in urine samples collected at home.

Authors:  Misaki Takakado; Yasunori Takata; Fumio Yamagata; Michiko Yaguchi; Go Hiasa; Sumiko Sato; Jun-Ichi Funada; Shoji Kawazu; Haruhiko Osawa
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02

10.  Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C.

Authors:  Frank Stämmler; Marcello Grassi; Jeffrey W Meeusen; John C Lieske; Surendra Dasari; Laurence Dubourg; Sandrine Lemoine; Jochen Ehrich; Eric Schiffer
Journal:  Diagnostics (Basel)       Date:  2021-12-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.